Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.


TSX:EDT - Post by User

Bullboard Posts
Comment by Spectracleson Jun 17, 2020 2:54am
178 Views
Post# 31158754

RE:RE:RE:Crickets.....

RE:RE:RE:Crickets..... I have no interest in selling and have been bolstering my position significantly. Been involved for so long now and the company has never looked better. Ali made one great point about the consolidation and why he and the company are in favour of it besides Nasdaq placement. At the moment we're at the mercy of those who play with the stock due to its low price. It's less likely to be shoved around when it's 6 or 7 bucks. Now we see 10% shifts over a very short span and that would be much harder with the higher price. The next test is when they reach 60% enrollment (most likely fall) in Tigris and Baxter has to say yeah or nay to further monetary involvement. Ali seemed to think it will go well. Dimi approval is coming soon and with COVID waning (mostly) the sales people will actually be able to enter hospitals to market and demo them and Dialco is prepared to pump out the pumps. And most likely early 2021 for FDA approval. My shares are locked and loaded.
Bullboard Posts